CLOTBUSTER Trademark
Trademark Overview
On Tuesday, May 28, 2024, a trademark application was filed for CLOTBUSTER with the United States Patent and Trademark Office. The USPTO has given the CLOTBUSTER trademark a serial number of 79399277. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Friday, December 13, 2024. This trademark is owned by Barry Davis. The CLOTBUSTER trademark is filed in the Medical Instrument Products category with the following description:
Physical exercise apparatus for medical purposes.
General Information
Serial Number | 79399277 |
Word Mark | CLOTBUSTER |
Filing Date | Tuesday, May 28, 2024 |
Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
Status Date | Friday, December 13, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Physical exercise apparatus for medical purposes. |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, July 4, 2024 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Barry Davis |
Party Type | 10 - Original Applicant |
Legal Entity Type | 98 - Unknown |
Address | AU |
Trademark Events
Event Date | Event Description |
Thursday, July 4, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Thursday, July 11, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, July 11, 2024 | APPLICATION FILING RECEIPT MAILED |
Tuesday, December 10, 2024 | ASSIGNED TO EXAMINER |
Friday, December 13, 2024 | NON-FINAL ACTION WRITTEN |
Saturday, December 14, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |